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Introduction
Testicular cancer (TC) affects men in a period of life when intimate relationships, star-
ting a family, and career are major concerns. Since the introduction of cisplatin-based 
chemotherapy in the late 1970s, TC has become one of the most curable malignancies, 
with cure rates between 85 and 90% [1;2]. As a consequence, the majority of men diag-
nosed with TC will live the largest part of their lives as cancer survivors and they may 
have to face sequel of diagnosis and treatment on different domains of their lives. The 
term “quality of life” (QoL) is generally used to refer to an individual’s perception of 
his well-being on, among others, the physical, psychological, and social domains [3]. In 
the research on testicular cancer survivors (TCSs), these domains already have received 
attention. For example, research on the physical domain shows that TCSs who were 
treated for metastetic disease have an increased risk of infertility, fatigue, second primary 
malignancies, decreased renal functioning, hearing deficits, and cardiovascular disease 
[4;5]. Studies that focused on the psychological and social domains showed that the 
majority of TCSs experiences good levels of functioning, although subsamples report 
psychosocial problems such as anxiety, depression, fertility distress, and work-related 
problems [6].
However, a review of the literature on the QoL of TCSs revealed that most of the exis-
ting literature on the QoL of TCSs suffers from methodological shortcomings, such as 
small sample sizes and the use of nonvalidated questionnaires [6]. Furthermore, there 
is a lack of research into the QoL of the growing group of long-term TCSs. Currently, 
there are only a few studies that did include long-term survivors [7-10], whereas at this 
point in time, approximately 25 years after the medical breakthrough in treatment, the 
group of long-term survivors has grown large enough to provide adequate statistical 
power to examine their QoL. Then again, the inclusion of long-term survivors does 
confront researchers with specific methodological concerns. In long-term survivors, it 
is more difficult to distinguish effects caused by cancer and its treatment, from those 
attributable to other factors, such as aging, comorbidities [11], and additionally expe-
rienced life events. The probability of having a functional limitation or chronic disease 
increases with advancing age [11], and this may affect QoL. In addition, it is likely that, 
over time, other life events may influence the current QoL more than the experience 
with cancer. Therefore, to be able to draw reliable conclusions about the QoL of TCSs, 
it is essential to investigate the impact of age, comorbidities, and recently experienced 
life events as well as that of cancer-related variables. Lastly, based on the available data, 
it is not possible to identify TCSs at risk for an impaired QoL. Because the endpoint 
of research should always be to bridge the gap with clinical practice [12], the identifica-
tion of risk groups should be a primary focus of QoL studies. Risk profiles may help 
clinicians to detect distressed TCSs in an early stage. This may lead to earlier referral to 
psychosocial services and as a consequence more patients may be spared from protracted 
distress [13]. 
The present study aims to attack the above-mentioned issues by (1) examining the QoL 
of a large sample of TCSs by comparing them to a reference group of Dutch men; (2) 
investigating the relationship of sociodemographics, cancer-related variables, and recent-
ly experienced life events with QoL and (3) identifying TCSs with an impaired QoL, 
FYN Werk-Fleer proefschrift.indb43   43 11-1-2006   23:43:52
344




All men treated for TC between 1977 and 2003 at the University Medical Center Gro-
ningen (UMCG) in The Netherlands were approached in writing for the present study. 
In 1977, cisplatin-based chemotherapy, which led to the improved survival rates, was 
introduced into the treatment of metastetic TC at the UMCG. Exclusion criteria were 
age younger than 18 years at study entry, insufficient command of the Dutch language, 
and time since completion of treatment shorter than 3 months. The decision to use the 
criterion of 3 months after completion of the last treatment was based on the clinical 
consideration that TC patients have a very good prognosis. A letter with information 
about the objectives of the study and an informed consent form were sent to the 702 
eligible TCSs. The study was approved of by the Medical Ethics Committee of the Uni-
versity Medical Center Groningen.
Measurements 
Data on the following sociodemographic variables were collected: age, educational level, 
marital status, employment status, and chronic disease. Highest educational level com-
pleted was measured on a seven-point scale: primary school (1), lower vocational degree 
(2), lower secondary (3), middle secondary (4), high secondary (5), higher vocational 
(6) and university (7). We define chronic disease as an illness marked by long duration 
or frequent recurrence and used two questions to measure the prevalence of a chronic 
disease. TCSs first responded to a yes/no question: “Do you have a chronic disease 
(e.g., asthma, multiple sclerosis, rheumatoid arthritis)?” If a TCS reported that he had a 
chronic disease, he was asked to describe the disease.
 In addition, the following cancer-related data were collected: age at diagnosis, time since 
completion of treatment, type of treatment, and whether they had experienced a second 
cancer event (either a tumor relapse or a second primary malignancy). Type of treatment 
could comprise: orchidectomy (surgical removal of the affected testicle), orchidectomy 
and a retroperitoneal lymph node dissection (RPLND), orchidectomy and radiothera-
py, orchidectomy and chemotherapy, or orchidectomy and chemotherapy and resection 
of residual tumor mass (RRTM). 
The RAND-36 [14] is an internationally used valid and reliable generic self-report ques-
tionnaire to assess QoL. The Dutch version of the RAND-36 [15] was used. It contains 
eight subscales: physical functioning (ten items), social functioning (two items), role 
limitations in work or other activities due to physical problems (four items), role limita-
tions in work or other activities due to emotional problems (three items), mental health 
(five items), vitality (two items), pain (two items), and general health perception (five 
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items). After recoding and transforming, scores of the subscales could range from 0 to 
100, with a higher score indicating better functioning. In the present study, internal con-
sistency (Cronbach alpha) of the subscales for the total group of TCSs varied between 
0.80 and 0.92. 
We used reference scores from the Dutch manual for the RAND-36 as comparison to 
the TCSs. These comprised the mean scores from a group of 372 nonselected men from 
a random sample of 1,063 persons aged 18 years and older from the population register 
of a municipality in the north of the Netherlands (number of inhabitants = 108,000). 
The mean age of the persons in the total random sample was 44.1 years (range 18-89 
years) [15].
Life events were measured with the Vragenlijst Recent Meegemaakte Gebeurtenissen 
(VRMG), a Dutch questionnaire to measure recently experienced life events [16]. This 
questionnaire contains 25 events around five themes: health, illness and death; preg-
nancy/birth; work; relationships, and miscellaneous (e.g., financial gain/loss, moving 
house, passing an exam). TCSs were asked to report whether they had experienced any 
of the 11 positive events and 14 negative events during the past year. Sum scores were 
calculated for the two subscales.
For TCSs, one self-constructed question was added to relate their experience with TC 
to their current QoL. TCSs responded to the question: “Do you think that your experi-
ence with testicular cancer affects your current QoL?” The following answers could be 
given: 1) “TC affects my current QoL very negatively”, 2) “TC affects my current QoL 
negatively”, 3) “TC affects my current QoL positively as well as negatively”, 4) “TC affects 
my current QoL positively”, 5) “TC affects my current QoL very positively”, 6) “TC does 
not affect my current QoL”. 
Statistical analyses 
To investigate differences between the TCSs and the reference group, independent T-
tests were performed. Effect sizes were calculated with Cohen’s d to assess the clinical 
significance of differences between TCSs and the reference group on the RAND-36. 
The interpretation of effect sizes is that a difference greater than 0.8 is large, between 
0.5 and 0.8 is moderate, between 0.2 and 0.5 is small, and a difference smaller than 0.2 
is insignificant [17]. 
Pearson correlations, T-tests, ANOVAs, and Mann-Whitney U tests were conducted 
to examine which sociodemographic variables, life events, and cancer-related variables 
were significantly related to the RAND-36 subscales. For employment status, a dichoto-
mous variable was created with the categories “not employed for wages” (consisting of 
students, being unemployed, being unable to work and being retired) and “employed for 
wages” (consisting of being employed for wages). The effect of time since completion of 
treatment was evaluated in two ways. First, correlational analyses were performed, and 
secondly, ANOVAs were conducted to compare survivors divided into five groups accor-
ding to time elapsed since completion of treatment. Group I, 3 months-2 years; Group II, 
2-5 years; Group III, 5-10 years; Group IV, 10-15 years; Group V, more than 15 years. The 
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effect of type of treatment was investigated on the basis of two classifications. Firstly, the 
four treatment groups were compared. Secondly, two treatment groups were compared: 
“surgical treatment” (consisting of the categories orchidectomy and orchidectomy plus 
RPLND) and “combined treatment” (consisting of the categories orchidectomy plus 
radiotherapy, orchidectomy plus chemotherapy and orchidectomy plus chemotherapy 
plus RRTM). The variables that were significantly related to the dependent variables in 
the univariate analyses were included in forward regression analyses. 
Results were considered statistically significant if the probability of occurrence was 0.05 
or less. Inasmuch as this is a descriptive study, no formal adjustments were employed to 
correct for multiple testing. Therefore, caution is warranted in interpretation of findings 
of p > 0.01.
Results
Descriptives 
Fifty percent (n = 354) of the TCSs approached agreed to participate. Of the TCSs who 
did not participate, 74 (21%) indicated their reason for refusal. Main reasons mentioned 
were lack of interest, the disease period was considered to be a closed book, and too 
much of a burden. Nonparticipants did not differ significantly on age, time since diag-
nosis, and type of treatment from the participants. 
The descriptives of the participants are summarized in Table 1. Mean age was 43.7 years, 
ranging from 18 to 78 years. Highest educational level completed varied from primary 
school to university degree, but the mean educational level was high secondary educa-
tion. Furthermore, most survivors were married or cohabiting (85%), employed for wa-
ges (78%), and did not have a chronic disease (85%). The TCSs who did have a chronic 
disease mainly reported having rheumatoid and degenerative diseases (26%), pulmonary 
diseases (23%) and cardiovascular diseases (19%). Noticeable, only one TCS reported 
that his lungs were damaged due to treatment with bleomycin. 
The mean time since completion of treatment was 10 years, ranging from 3 months to 
24 years. Because age at diagnosis correlated highly with age (r = 0.83, p < 0.001), it 
was decided to leave age at diagnosis out of further analyses. The correlation between 
age and time since completion of treatment was lower (r = 0.43, p = 0.001), and there-
fore, both variables were taken into account in further analyses. The minority of TCSs 
(34.5%) was treated with surgical treatment (orchidectomy ± RPLND) and almost 9% 
of the survivors had experienced a second cancer event (recurrence, second TC, or other 
cancer tumor) (Table 1). 
QoL of TCSs: comparison with a reference group
Independent T-tests showed that TCSs reported better physical functioning (t = 2.4, 
p < .05) and less pain (t = 3.3, p = .001) than the reference group of men, but a worse 
mental health (t = -2.03, p < 0.05) and less vitality (t = -3.5, p < 0.001). However, the 
effect sizes of the differences were small for the subscales vitality and pain and insignifi-
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*N is slightly variable because of missing data. 
aeducational level was measured on a seven-point scale, ranging from primary school (1) 
to university degree (7); bRPLND = retroperitoneal lymph node dissection; cRRTM = 
resection of residual tumor mass
TCSs (N = 354*)
Age (in years) mean, range 43.7 18.4-78.5
Educational levela mean, SD 4.2 1.7
Marital status N, %
Single/divorced/separated 53 15
Married/cohabiting/LAT 300 85
Employment status N, %
Employed for wages 275 77.9
Student 12 3.4
Out of work 6 1.7





Chronic disease N, %
No 299 84.9
Yes 53 15.1
Life events mean, SD
Positive 1.6 2.0
Negative 1.3 1.6
Time since treatment (in years) mean, SD 10.0 6.7
Treatment N,%
Surgical treatment 121 34.5
Orchidectomy 99 28.2
Orchidectomy + RPLNDb 22 6.3
Combined treatment 230 65.6
Orchidectomy + radiotherapy 68 19.4
Orchidectomy + chemotherapy 53  15.1
Orchidectomy + chemotherapy + RRTMc 109 31.1
Second cancer event N, %
Yes 31 8.8
No 322 91.2
Table 1. Sample characteristics
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cant for the other subscales. This indicates that the statistically significant differences are 
not clinically relevant (Table 2). 
Associations between sociodemographic and cancer-related variables and life 
events and QoL of TCSs 
A significant negative correlation was found between age and physical functioning, pain, 
and general health perception (all p < 0.001). Furthermore, a significant positive re-
lationship was found between educational level and physical functioning (p < 0.001). 
Positive life events was not significantly correlated to any of the RAND-36 subscales, 
but a significant negative association was found between the experience of more negative 
life events and social functioning (p < 0.05), role limitations (emotional) (p < 0.01) and 
mental health (p < 0.05). Time since treatment correlated significantly negatively with 
physical functioning (p < 0.05) (Table 3). When TCSs were divided in time-cohorts 
based on time since treatment, it appeared that no significant differences were found 
between the cohorts on any of the RAND-36 subscales.
Married TCSs reported significantly better mental health (t = -2.23, p < 0.05). TCSs who 
were employed for wages reported significantly better physical functioning (t = -4.42, 
p  = 0.001), social functioning (t = -3.46, p = 0.001), fewer role limitations due to physi-
cal problems (t = -2.86, p < 0.01), better mental health (t = -3.28, p = 0.001), more vita-
lity (t = -3.60, p < 0.001), less pain (t = -3.53, p = 0.001), and a better general health 
perception (t = -5.09, p < 0.001) than did those who were not employed for wages. TCSs 
without a chronic disease had significantly higher mean scores on the subscales physical 
functioning (t = -3.78, p < 0.001), social functioning (t = -3.00, p < 0.05), role limitations 
due to physical problems (t = -2.49, p < 0.05), role limitations due to emotional problems 
Table 2. Means and standard deviations for the RAND-36 subscales for TCSs 
and the reference group and T-tests between the two groups
TCSs Reference group
Mean SD Mean SD t p-value
Effect 
size
Physical functioning 88 19 85 22 2.41 0.02 0.18
Social functioning 86 20 88 20 -1.84 0.07 -0.14
Role limitations (physical) 84 31 82 34 1.05 0.29 0.08
Role limitations (emotional) 85 31 87 29 -0.85 0.40 -0.06
Mental health 77 16 79 17 -2.03 0.04 -0.15
Vitality 64 20 70 21 -3.50 <0.001 -0.26
Pain 88 19 83 24 3.28 0.001 0.24
General health perception 71 20 71 23 -0.02 0.95 0.00
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(t = -2.07, p < 0.05), mental health (t = -2.60, p < 0.05), vitality (t = -2.74, p < 0.01), pain 
(t = -2.74, p < 0.01), and general health perception (t = -5.18, p < 0.001) than did those 
with a chronic disease.
ANOVAs with type of treatment in four cohorts did not show significant effects of 
type of treatment received on any of the QoL subscales (results not reported in table). 
However, when type of treatment was divided in two cohorts, results showed that TCSs 
who had received combined treatment had significantly lower mean scores on vitality 
(t = 2.00, p < .05) and general health perception (t = 2.55 , p = 0.01) than those who had 
received surgical treatment only. Finally, TCSs who had experienced a second cancer event 
reported worse mental health (t = -2.12 , p < 0.01) and general health perception (t = -3.14, 
p < 0.01) than TCSs who had not experienced a second cancer event (Table 4).
Univariate analyses showed that both employment status and chronic disease signifi-
cantly related to all QoL subscales, except for role limitations due to emotional pro-
blems. Because not being employed for wages may be a result of having a chronic disease, 
it was decided to create a composite variable, which resulted in the following groups:
Group 1, not employed for wages and with a chronic disease (n = 24); 
Group 2, employed for wages and with a chronic disease (n = 29); 
Group 3, not employed for wages and without a chronic disease (n = 54); 
Group 4, employed for wages and without a chronic disease (n = 245).
ANOVA, followed by a Scheffé-test, showed that group 1 differed significantly from the 










r r r r r
Physical functioning  -0.29*** 0.20*** 0.10 -0.06 -0.12*
Social functioning -0.06 0.01 0.03 -0.12* -0.02
Role limitations (physical) -0.12* 0.08 -0.02 -0.08 0.05
Role limitations (emotional) -0.002 -0.07 -0.006 -0.15** -0.01
Mental health 0.009 -0.02 0.01 -0.14* 0.01
Vitality -0.05 0.03 0.07 -0.09 0.004
Pain -0.25*** 0.09 0.08 -0.05 -0.09
General health perception -0.19*** 0.08 0.08 -0.08 -0.02
Table 3. Pearson correlations between continuous sociodemographic variables, 
life events, and cancer-related variables with the RAND-36 subscales
*p≤0.05; **p≤0.01; ***p≤0.001
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(F = 11.62, p < 0.001), role limitations due to physical problems (F = 9.78, p < 0.001), pain 
(F = 9.50, p < .001), and general health perception (F = 20.02, p < 0.001). Group 1 differed 
significantly from group 4 on mental health (F = 7.96, p < 0.001) and vitality (F = 6.62, 
p < 0.001). Therefore, a dummy variable of this composite variable was created for which 
group 1 was separated from the remaining three groups (dummy variable, 0 = TCSs who 
were not employed for wages and had a chronic disease; 1 = the rest). This dummy variable 
was included in the stepwise forward regression analyses instead of the individual variables 
of employment status and chronic disease for all subscales, except for role limitations due 
to emotional problems. 
Predictors of QoL
Because the third aim of this study was to identify TCSs with an impaired QoL, regres-
sion analyses were performed to determine which variables had the strongest predictive 
power. Only the variables that were significantly related to the dependent variables in the 
univariate analyses were included in the forward regression analyses. The dummy vari-
able of employment status and chronic disease appeared to be the strongest predictor, 
indicating that the combination of not being employed for wages and having a chronic 
disease had a particularly negative effect on the QoL of TCSs. Age and educational level 
had significant independent predictive power in physical functioning, age had also an 
independent effect on pain and general health perception. The experience of negative life 
events had a unique negative effect on social functioning, role limitations (emotional) 
and mental health. With respect to cancer-related variables, type of treatment appeared 
to have some explanatory power in vitality and general health perception and the ex-
perience of a second cancer event in mental health and general health perception. The 
univariate effects of marital status and time since completion of treatment disappeared 
in the regression analyses. 
The selected variables in the regression models explained significant, although small, 
proportions of the variance of the subscales of the RAND-36 (ranging from 4% to 22%) 
(Table 5). 
Evaluation of the impact of TC on current QoL
As a response to the question “do you think that the experience with TC affects your 
current QoL?” 52.6% of the TCSs reported that it had a negative as well as a positive 
impact on their current QoL. A small percentage (11.2%) of the TCSs reported that the 
experience with TC still had a negative or very negative impact, 26.6% reported that it 
had a (very) positive impact, and 9.5% reported that it had no impact at all. TCSs who 
were not employed for wages and who had a chronic disease differed from the rest of the 
TCSs in their answers to this question: a significantly larger proportion of this group 
reported that TC still had a negative impact on their present QoL (33.3% vs. 9.7%, Chi2 
= 12.90, p = 0.005). 
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Discussion
Examination of the quality of life (QoL) of testicular cancer survivors (TCSs) was the 
first objective of this study. Overall, the TCSs in our study reported relatively high levels 
of QoL. However, some statistically significant differences between TCSs and refer-
ence men were found. TCSs reported a better physical functioning and less bodily pain, 
but worse mental functioning and less vitality. Yet, the effect sizes of the statistical diffe-
rences were small to negligible. These results are consistent with those of other studies 
reporting no differences between TCSs and controls in QoL [9;18] and more generally 
consistent with the results of studies on other types of cancers [19-21]. Parker et al. [21] 
explained this lack of difference by arguing that “patients may be taking their cancer 
diagnosis in consideration when they subjectively evaluate their health status and func-
tioning”. Indeed, it may very well be that the experience with cancer changes their expec-
tations about life or internal standards and causes one to evaluate ones QoL according 
to new expectations or different standards [22].
Secondly, we were interested in the relationship between the QoL of TCSs and socio-
demographics, cancer-related variables, and life events. Consistent with findings in the 
general population [15], our results showed an aging effect in the physical domain, with 
older TCSs reporting a decline in functioning. We also expected to find more QoL 
problems in TCSs who were more recently treated. Contrary to our expectations, we 
did not find an effect of time since treatment. QoL of TCSs was comparable among the 
short-, median-, and long-term survivors, indicating that survivors quickly adapt to the 
circumstances created by the experience of cancer treatment. 
Employment status and chronic disease were found to be the most important predictors 
of QoL of TCSs. More precisely, the combination of employment status and chronic 
disease appeared to be the strongest predictor. The mean scores of the group of unem-
ployed TCSs with a chronic disease deviated significantly from those of men who only 
had a chronic disease, were only unemployed, or who neither suffered from a chronic 
disease or unemployment. This joint burden of unemployment and chronic disease on 
QoL has not been studied before in TCSs, but its negative effect on well-being has been 
found in the general population [23]. The relationship between these two variables is 
understandable when it is considered that chronic diseases can cause impairments in 
social activities and work, which may lead to lower levels of QoL [24-27]. If and how 
the experience with TC relates to these findings cannot be determined on the basis of 
the available data, but responses to an open question indicate that unemployed TCSs 
with a chronic disease significantly more often experience a negative impact of TC on 
their current QoL than their counterparts. So, it might be that the experience with TC 
has impacted through chronic disease and employment status on the well-being of these 
men, but prospective research is needed to verify this result.
Having or not having a partner did not affect functioning in TCSs, whereas having a 
partner has been identified as an predictor of better well-being in the general population 
[21]. One line of reasoning to explain this result might be that TCSs without a partner 
may attribute their being single to the experience with TC (“external attribution”) [28] 
and this might have led to a reevaluation of having a partner as being less important for 
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their well-being than, for example, being employed. More research is needed to deter-
mine if this is the case. 
TCSs who were treated with combined treatment reported less vitality and a worse 
general health perception than those who had received surgery only. Furthermore, TCSs 
who had received treatment for a second cancer event reported a worse mental health 
and a worse general health perception than those who did not encounter a second cancer 
event. Although these relationships make sense, the impact of these variables was low. 
This lack of effect of objective illness-related variables on QoL has been reported previ-
ously [21;29]. It may be that the subjective perception of the seriousness or threat of the 
disease is a more important determinant of QoL [30]. 
The impact of positive life events was an insignificant predictor, but the experience of 
more negative life events during the past year was related to more limitations in emo-
tional and social well-being. This is consistent with the general assumption that expo-
sure to a cumulative number of negative life events is associated with more psychosocial 
problems [31]. Recently experienced negative life events influenced the current QoL of 
the TCSs to a greater extent than objective cancer-related variables.
Limitations
The inclusion of a validated generic QoL questionnaire, the large sample size, and the 
large range in time since treatment are strengths in the design of this study. However, 
this study has some limitations as well. First of all, the response rate of 50% may have 
induced bias, although the participating TCSs did not differ in age, time since diagnosis, 
and type of treatment from those who did not participate. Matsuda et al. [32] have sum-
marized several characteristics of nonresponders and gender was one of them. Men tend 
to have a lower response rate than women, so this might partly explain the relatively low 
response rate in the present study. A further limitation was that chronic disease was 
measured somewhat crudely: respondents were not asked to indicate their perception 
of the severity of the chronic disease and whether they thought that the chronic disease 
was a consequence of the treatment for TC. Finally, based on a previous report [33], 
we decided to dichotomizes employment status into employment for wages and not 
employed for wages. The last group included students as well as retirees, and this may 
have resulted in a biased picture of the results. However, we also performed analyses 
with other dichotomizations (for example, dichotomizations in which students and/or 
retirees were left out), and this did not give different results (not reported in the results 
section). 
Summary and conclusions
In conclusion, the results of the present study show that, on the whole, TCSs experience 
a QoL similar to that of men who did not experience cancer. Age, employment status, 
chronic disease, and negative life events were more important determinants of QoL than 
objective disease characteristics and should be taken into account when considering the 
QoL of cancer survivors over time. TCSs who are not employed for wages and who have 
a chronic disease seemed to be at risk for an impaired functioning. Finally, it should be 
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noted that the variance explained by sociodemographic variables, life events, and can-
cer-related variables was low, indicating that more important predictors remain to be 
identified.
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